vs
EMPIRE PETROLEUM CORP(EP)与礼来(RNA)财务数据对比。点击上方公司名可切换其他公司
礼来的季度营收约是EMPIRE PETROLEUM CORP的1.8倍($12.5M vs $7.1M),EMPIRE PETROLEUM CORP净利率更高(-835.1% vs -1398.3%,领先563.2%),礼来同比增速更快(434.0% vs -30.0%),过去两年礼来的营收复合增速更高(138.5% vs -13.3%)
伊拉克石油公司,前身为土耳其石油公司,是一家石油企业,1925年至1961年间几乎垄断了伊拉克境内所有石油勘探与开采业务,由当时全球多家顶尖石油企业共同持股,公司总部设立于英国伦敦。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,在18个国家设有办事处,产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立,品牌名即取自创始人姓名。
EP vs RNA — 直观对比
营收规模更大
RNA
是对方的1.8倍
$7.1M
营收增速更快
RNA
高出464.1%
-30.0%
净利率更高
EP
高出563.2%
-1398.3%
两年增速更快
RNA
近两年复合增速
-13.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $7.1M | $12.5M |
| 净利润 | $-59.0M | $-174.4M |
| 毛利率 | — | — |
| 营业利润率 | -834.5% | -1513.5% |
| 净利率 | -835.1% | -1398.3% |
| 营收同比 | -30.0% | 434.0% |
| 净利润同比 | -1306.0% | -117.0% |
| 每股收益(稀释后) | $-1.74 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EP
RNA
| Q4 25 | $7.1M | — | ||
| Q3 25 | $9.4M | $12.5M | ||
| Q2 25 | $8.8M | $3.8M | ||
| Q1 25 | $9.0M | $1.6M | ||
| Q4 24 | $10.1M | $3.0M | ||
| Q3 24 | $11.4M | $2.3M | ||
| Q2 24 | $12.8M | $2.0M | ||
| Q1 24 | $9.4M | $3.5M |
净利润
EP
RNA
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $-3.8M | $-174.4M | ||
| Q2 25 | $-5.1M | $-157.3M | ||
| Q1 25 | $-4.2M | $-115.8M | ||
| Q4 24 | $-4.2M | $-102.3M | ||
| Q3 24 | $-3.6M | $-80.4M | ||
| Q2 24 | $-4.4M | $-70.8M | ||
| Q1 24 | $-4.0M | $-68.9M |
营业利润率
EP
RNA
| Q4 25 | -834.5% | — | ||
| Q3 25 | -37.8% | -1513.5% | ||
| Q2 25 | -56.0% | -4448.7% | ||
| Q1 25 | -43.9% | -8360.9% | ||
| Q4 24 | -38.9% | -4069.6% | ||
| Q3 24 | -30.0% | -4200.9% | ||
| Q2 24 | -15.0% | -4040.4% | ||
| Q1 24 | -46.8% | -2178.6% |
净利率
EP
RNA
| Q4 25 | -835.1% | — | ||
| Q3 25 | -40.9% | -1398.3% | ||
| Q2 25 | -57.8% | -4089.3% | ||
| Q1 25 | -46.9% | -7360.0% | ||
| Q4 24 | -41.6% | -3439.5% | ||
| Q3 24 | -32.0% | -3441.7% | ||
| Q2 24 | -34.3% | -3461.8% | ||
| Q1 24 | -42.3% | -1943.4% |
每股收益(稀释后)
EP
RNA
| Q4 25 | $-1.74 | — | ||
| Q3 25 | $-0.11 | $-1.27 | ||
| Q2 25 | $-0.15 | $-1.21 | ||
| Q1 25 | $-0.12 | $-0.90 | ||
| Q4 24 | $-0.12 | $-0.80 | ||
| Q3 24 | $-0.12 | $-0.65 | ||
| Q2 24 | $-0.15 | $-0.65 | ||
| Q1 24 | $-0.15 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-4.6M | $1.9B |
| 总资产 | $65.9M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
EP
RNA
| Q4 25 | $1.2M | — | ||
| Q3 25 | $4.6M | $350.2M | ||
| Q2 25 | $2.3M | $243.9M | ||
| Q1 25 | $1.1M | $254.2M | ||
| Q4 24 | $2.3M | $219.9M | ||
| Q3 24 | $3.1M | $370.2M | ||
| Q2 24 | $9.3M | $575.8M | ||
| Q1 24 | $3.5M | $471.4M |
总债务
EP
RNA
| Q4 25 | — | — | ||
| Q3 25 | $15.2M | — | ||
| Q2 25 | $14.6M | — | ||
| Q1 25 | $11.6M | — | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $8.5M | — | ||
| Q1 24 | $8.5M | — |
股东权益
EP
RNA
| Q4 25 | $-4.6M | — | ||
| Q3 25 | $53.7M | $1.9B | ||
| Q2 25 | $54.5M | $1.2B | ||
| Q1 25 | $59.1M | $1.3B | ||
| Q4 24 | $62.8M | $1.4B | ||
| Q3 24 | $56.5M | $1.5B | ||
| Q2 24 | $58.7M | $1.2B | ||
| Q1 24 | $31.7M | $830.9M |
总资产
EP
RNA
| Q4 25 | $65.9M | — | ||
| Q3 25 | $123.0M | $2.1B | ||
| Q2 25 | $124.7M | $1.4B | ||
| Q1 25 | $123.7M | $1.5B | ||
| Q4 24 | $123.9M | $1.6B | ||
| Q3 24 | $121.2M | $1.6B | ||
| Q2 24 | $119.9M | $1.3B | ||
| Q1 24 | $100.1M | $951.5M |
负债/权益比
EP
RNA
| Q4 25 | — | — | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | 0.15× | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-156.9M |
| 自由现金流率自由现金流/营收 | — | -1257.6% |
| 资本支出强度资本支出/营收 | — | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-592.3M |
8季度趋势,按日历期对齐
经营现金流
EP
RNA
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $330.0K | $-156.2M | ||
| Q2 25 | $-3.1M | $-199.7M | ||
| Q1 25 | $1.6M | $-124.8M | ||
| Q4 24 | $-8.8M | $-99.9M | ||
| Q3 24 | $12.8M | $-65.6M | ||
| Q2 24 | $-1.8M | $-65.0M | ||
| Q1 24 | $3.9M | $-70.4M |
自由现金流
EP
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-156.9M | ||
| Q2 25 | — | $-203.0M | ||
| Q1 25 | — | $-128.6M | ||
| Q4 24 | — | $-103.8M | ||
| Q3 24 | — | $-67.3M | ||
| Q2 24 | — | $-65.5M | ||
| Q1 24 | — | $-71.3M |
自由现金流率
EP
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | -1257.6% | ||
| Q2 25 | — | -5277.1% | ||
| Q1 25 | — | -8174.3% | ||
| Q4 24 | — | -3491.0% | ||
| Q3 24 | — | -2881.8% | ||
| Q2 24 | — | -3204.6% | ||
| Q1 24 | — | -2012.3% |
资本支出强度
EP
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 86.9% | ||
| Q1 25 | — | 238.6% | ||
| Q4 24 | — | 131.7% | ||
| Q3 24 | — | 72.9% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图